Softec HD hydrophilic acrylic intraocular lens: biocompatibility and precision
Ladan Espandar1, Shameema Sikder2, Majid Moshirfar3
1Department of Ophthalmology, Tulane University, New Orleans, LA, USA; 2Wilmer Eye Institute, Johns Hopkins University, Baltimore, MD, USA; 3John A Moran Eye Center, University of Utah, Salt Lake City, UT, USA
Abstract: Intraocular lens development is driven by higher patient expectations for ideal visual outcomes. The recently US Food and Drug Administration-approved Softec HD™ lens is an aspheric, hydrophilic acrylic intraocular lens (IOL). The hydrophilic design of the lens is optimized to address dysphotopsia while maintaining biocompatibility, optical clarity, resistance to damage, and resistance to biocontamination. Aspheric lenses decrease postoperative spherical aberration. The addition of the Softec lens provides clinicians with another option for IOL placement; however, randomized comparative studies of this lens to others already on the market remain to be completed.
Keywords: hydrophilic acrylic intraocular lens, Softec HD intraocular lens, aspheric intraocular lens, IOL
Corrigendum for this paper has been published
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.Download Article [PDF] View Full Text [HTML][Machine readable]